Yee-Ming Chan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Yee-Ming Chan has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
- Sarabeth Broder-Fingert
Department of Pediatrics, University of Massachusetts Chan Medical School, Worchester, USA
3 shared publications Stephanie B. Seminara
Harvard Reproductive Sciences Center and Reproductive Endocrine Unit (Y.-M.C., V.F.S., N.E.P., S.B.S.), Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114
3 shared publicationsJames P. Butler
Division of Endocrinology, Children's Hospital Boston, and Department of Medicine (J.P.B.), Division of Sleep Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115
2 shared publicationsNancy E. Pinnell
Harvard Reproductive Sciences Center and Reproductive Endocrine Unit (Y.-M.C., V.F.S., N.E.P., S.B.S.), Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114
2 shared publications- Stephanie Beth Seminara
Harvard Reproductive Sciences Center and Reproductive Endocrine Unit, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA
2 shared publications Adelaide De Guillebon
1 shared publication
Latest Publications
- 16 February 2013
- Published by Springer Nature
- Vol. 784, 89-112
Effects of Kisspeptin on Hormone Secretion in Humans
Studies of the actions of kisspeptin in human subjects have examined the effects of different kisspeptin isoforms, doses, and routes of administration on LH secretion, a surrogate measure of GnRH release. These studies, in addition to detailing how these different variables affect LH secretion in response to kisspeptin, have produced new insights into kisspeptin physiology: (1) Brief exposure to kisspeptin results in sustained GnRH release lasting ~17 min in men. (2) Women in different phases of the menstrual cycle have differences in their response to kisspeptin, suggesting that endogenous kisspeptin secretion and GnRH neuronal responsiveness vary in response to the changing sex-steroid environment across the menstrual cycle. (3) Kisspeptin resets the GnRH pulse generator in men, but does not appear to do so in women. (4) Continuous exposure to kisspeptin results in desensitization to kisspeptin, and thus kisspeptin has the potential to either stimulate or suppress reproductive endocrine activity depending on the mode of administration. These findings pave the way for future studies using kisspeptin as a physiologic, diagnostic, and therapeutic tool in both healthy adults and in patients with reproductive disorders.
- 16 February 2013
- Published by Springer Nature
- Vol. 784, 89-112
Effects of Kisspeptin on Hormone Secretion in Humans
Studies of the actions of kisspeptin in human subjects have examined the effects of different kisspeptin isoforms, doses, and routes of administration on LH secretion, a surrogate measure of GnRH release. These studies, in addition to detailing how these different variables affect LH secretion in response to kisspeptin, have produced new insights into kisspeptin physiology: (1) Brief exposure to kisspeptin results in sustained GnRH release lasting ~17 min in men. (2) Women in different phases of the menstrual cycle have differences in their response to kisspeptin, suggesting that endogenous kisspeptin secretion and GnRH neuronal responsiveness vary in response to the changing sex-steroid environment across the menstrual cycle. (3) Kisspeptin resets the GnRH pulse generator in men, but does not appear to do so in women. (4) Continuous exposure to kisspeptin results in desensitization to kisspeptin, and thus kisspeptin has the potential to either stimulate or suppress reproductive endocrine activity depending on the mode of administration. These findings pave the way for future studies using kisspeptin as a physiologic, diagnostic, and therapeutic tool in both healthy adults and in patients with reproductive disorders.
- 1 September 2012
- Published by Wolters Kluwer Health in Obstetrical & Gynecological Survey
- Vol. 67 (9) , 546-547
GnRH-Deficient Phenotypes in Humans and Mice With Heterozygous Variants in KISS1/Kiss1
Defects in a number of genes have been implicated in the pathophysiology of GnRH deficiency. Several lines of evidence suggest that KISS1 is a likely candidate gene for GnRH deficiency. These include identification of inactivating mutations in KISS1R (a.k.a. GPR54) in patients with GnRH deficiency, targeted deletions of either KISS1 or KISS1R in mice with hypogonadotropic phenotypes, and the demonstrated role of kisspeptin in stimulation of GnRH neurons and initiation of puberty. However, no inactivating mutations in KISS1 have been found in patients with GnRH deficiency. The aim of this study was to identify deleterious mutations in KISS1. After a systematic evaluation of genetic variation identified rare sequence variants (RSV) in KISS1 among 1025 probands with GnRH deficiency, the frequency and functional significance of RSV were studied. DNA sequencing was performed in RSV of all probands and controls with normal reproductive function (n = 535). In addition to human studies, reproductive phenotypes in heterozygous and double-heterozygous KISS1 and KISS1R mice were examined to test the hypothesis that heterozygous mutations in KISS1 can cause reproductive deficits either alone or in combination with mutations in other genes. Individual variants located within the mature kisspeptin peptide were added to CHO-KISS1R cells to measure the accumulation of inositol phosphate. Variants located outside the peptide coding region were also analyzed in vitro and in silico. Transcriptional efficiency of the g.1→3659C3T variant was examined in vitro. Among the 1025 probands, 15 carried heterozygous RSV in KISS1 seen in less than 1% of the controls. Of 5 variants located within the mature kisspeptin peptide, p.F117L (but not p.S77I, p.Q82K, p.H90D, or p.P110T) reduced inositol phosphate generation in vitro. Analysis in silico showed that 2 variants residing within the coding region but outside the mature peptide, p.G35S and p.C53R (but not p.A129V), were predicted to be inactivating. One variant residing outside the coding region (g.1→3659C3T impairs transcription in vitro and another (c.1→7C3T) lies within the consensus Kozak sequence. Four of 5 probands tested had abnormal endogenous LH pulse patterns at baseline. In the mouse model, serum testosterone concentration decreased with increasing heterozygous loss of Kiss1 and Kiss1r alleles [wild-type, 274 (99) vs double heterozygotes, 69 (16) ng/dL; r2 = 0.13; P = 0.03]. Compared with wild-type mice, Kiss1/Kiss1r double-heterozygote males had shorter anogenital distances [13.0 (0.2) vs 15.6 (0.2) mm at P34, P < 0.001] and females had longer estrous cycles [7.4 (0.2) vs 5.6 (0.2) days, P < 0.01]. In addition, mating pairs had decreased litter frequency [0.59 (0.09) vs 0.71 (0.06) litters/month, P < 0.04] and size [3.5 (0.2) vs 5.4 (0.3) pups/litter, P < 0.001]. These findings show that rare, deleterious, heterozygous variants in KISS1, which seem to be associated with GnRH deficiency and abnormal reproductive phenotypes in humans, exist. GnRH deficiency in humans is not caused by KISS1 RSV alone. As in the mouse model, it may result from heterozygous KISS1 variants acting in concert with other genetic factors and/or environmental factors.
- 1 September 2012
- Published by Wolters Kluwer Health in Obstetrical & Gynecological Survey
- Vol. 67 (9) , 546-547
GnRH-Deficient Phenotypes in Humans and Mice With Heterozygous Variants in KISS1/Kiss1
Defects in a number of genes have been implicated in the pathophysiology of GnRH deficiency. Several lines of evidence suggest that KISS1 is a likely candidate gene for GnRH deficiency. These include identification of inactivating mutations in KISS1R (a.k.a. GPR54) in patients with GnRH deficiency, targeted deletions of either KISS1 or KISS1R in mice with hypogonadotropic phenotypes, and the demonstrated role of kisspeptin in stimulation of GnRH neurons and initiation of puberty. However, no inactivating mutations in KISS1 have been found in patients with GnRH deficiency. The aim of this study was to identify deleterious mutations in KISS1. After a systematic evaluation of genetic variation identified rare sequence variants (RSV) in KISS1 among 1025 probands with GnRH deficiency, the frequency and functional significance of RSV were studied. DNA sequencing was performed in RSV of all probands and controls with normal reproductive function (n = 535). In addition to human studies, reproductive phenotypes in heterozygous and double-heterozygous KISS1 and KISS1R mice were examined to test the hypothesis that heterozygous mutations in KISS1 can cause reproductive deficits either alone or in combination with mutations in other genes. Individual variants located within the mature kisspeptin peptide were added to CHO-KISS1R cells to measure the accumulation of inositol phosphate. Variants located outside the peptide coding region were also analyzed in vitro and in silico. Transcriptional efficiency of the g.1→3659C3T variant was examined in vitro. Among the 1025 probands, 15 carried heterozygous RSV in KISS1 seen in less than 1% of the controls. Of 5 variants located within the mature kisspeptin peptide, p.F117L (but not p.S77I, p.Q82K, p.H90D, or p.P110T) reduced inositol phosphate generation in vitro. Analysis in silico showed that 2 variants residing within the coding region but outside the mature peptide, p.G35S and p.C53R (but not p.A129V), were predicted to be inactivating. One variant residing outside the coding region (g.1→3659C3T impairs transcription in vitro and another (c.1→7C3T) lies within the consensus Kozak sequence. Four of 5 probands tested had abnormal endogenous LH pulse patterns at baseline. In the mouse model, serum testosterone concentration decreased with increasing heterozygous loss of Kiss1 and Kiss1r alleles [wild-type, 274 (99) vs double heterozygotes, 69 (16) ng/dL; r2 = 0.13; P = 0.03]. Compared with wild-type mice, Kiss1/Kiss1r double-heterozygote males had shorter anogenital distances [13.0 (0.2) vs 15.6 (0.2) mm at P34, P < 0.001] and females had longer estrous cycles [7.4 (0.2) vs 5.6 (0.2) days, P < 0.01]. In addition, mating pairs had decreased litter frequency [0.59 (0.09) vs 0.71 (0.06) litters/month, P < 0.04] and size [3.5 (0.2) vs 5.4 (0.3) pups/litter, P < 0.001]. These findings show that rare, deleterious, heterozygous variants in KISS1, which seem to be associated with GnRH deficiency and abnormal reproductive phenotypes in humans, exist. GnRH deficiency in humans is not caused by KISS1 RSV alone. As in the mouse model, it may result from heterozygous KISS1 variants acting in concert with other genetic factors and/or environmental factors.
- Open Access
- 1 August 2012
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 97 (8) , E1458-E1467
Kisspeptin Administration to Women: A Window into Endogenous Kisspeptin Secretion and GnRH Responsiveness across the Menstrual Cycle
Context: Kisspeptin is the most powerful known stimulus of GnRH-induced LH secretion across mammalian species. However, the effects of kisspeptin are just being explored, and the dynamics of kisspeptin responsiveness across the menstrual cycle are incompletely understood. Objective: The objective of the study was to characterize the effects of kisspeptin on GnRH secretion in healthy women in different phases of the menstrual cycle. Participants and Intervention: Ten women in the early follicular phase, three women in the late follicular (preovulatory) phase, and 14 women in the midluteal phase received a bolus of kisspeptin 112–121 0.24 nmol/kg iv. An additional four women in the early to midfollicular phase received kisspeptin 112–121 0.72 nmol/kg iv. Results: The response to kisspeptin varied depending on the phase of the menstrual cycle. LH pulses were observed immediately after kisspeptin administration in all luteal and preovulatory women. However, only half the women in the early follicular phase had unambiguous kisspeptin responses. Increasing the kisspeptin dose did not increase the LH response in early to midfollicular phase women. Kisspeptin did not appear to reset the GnRH pulse generator in women as it does in men. Conclusions: Differences in responses to exogenous kisspeptin across the menstrual cycle suggest that kisspeptin tone is higher in the early follicular phase compared with other cycle phases. The mechanisms that determine the timing of GnRH pulse generation in men and women appear to be distinct.
- 1 August 2012
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 97 (8) , E1458-E1467
Open AccessKisspeptin Administration to Women: A Window into Endogenous Kisspeptin Secretion and GnRH Responsiveness across the Menstrual Cycle
Context: Kisspeptin is the most powerful known stimulus of GnRH-induced LH secretion across mammalian species. However, the effects of kisspeptin are just being explored, and the dynamics of kisspeptin responsiveness across the menstrual cycle are incompletely understood. Objective: The objective of the study was to characterize the effects of kisspeptin on GnRH secretion in healthy women in different phases of the menstrual cycle. Participants and Intervention: Ten women in the early follicular phase, three women in the late follicular (preovulatory) phase, and 14 women in the midluteal phase received a bolus of kisspeptin 112–121 0.24 nmol/kg iv. An additional four women in the early to midfollicular phase received kisspeptin 112–121 0.72 nmol/kg iv. Results: The response to kisspeptin varied depending on the phase of the menstrual cycle. LH pulses were observed immediately after kisspeptin administration in all luteal and preovulatory women. However, only half the women in the early follicular phase had unambiguous kisspeptin responses. Increasing the kisspeptin dose did not increase the LH response in early to midfollicular phase women. Kisspeptin did not appear to reset the GnRH pulse generator in women as it does in men. Conclusions: Differences in responses to exogenous kisspeptin across the menstrual cycle suggest that kisspeptin tone is higher in the early follicular phase compared with other cycle phases. The mechanisms that determine the timing of GnRH pulse generation in men and women appear to be distinct.
- 1 October 2011
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 346 (1-2) , 51-56
A needle in a haystack: Mutations in GNRH1 as a rare cause of isolated GnRH deficiency
- 1 October 2011
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 346 (1-2) , 51-56
A needle in a haystack: Mutations in GNRH1 as a rare cause of isolated GnRH deficiency
- Open Access
- 1 June 2011
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 96 (6) , E908-E915
Kisspeptin Resets the Hypothalamic GnRH Clock in Men
Context: Reproduction in all mammals is controlled by a hypothalamic clock that produces periodic secretory pulses of GnRH, but how the timing of these pulses is determined is poorly understood. The neuropeptide kisspeptin potently and selectively stimulates the secretion of GnRH. Although this property of kisspeptin is well described, the effects of kisspeptin on endogenous GnRH pulse generation remain largely unexplored. Objective: The objective of the study was to detail the effects of kisspeptin on GnRH secretion, as reflected by LH secretion, in men. Participants: Thirteen healthy adult men participated in the study. Intervention: The intervention was the administration of a single iv bolus of the C-terminal decapeptide of kisspeptin (amino acids 112–121 of the parent protein). Results: Kisspeptin induced an immediate LH pulse, regardless of the timing of the previous endogenous pulse. The kisspeptin-induced pulses were on average larger than endogenous pulses (amplitude 5.0 ± 1.0 vs. 2.1 ± 0.3 mIU/ml, P = 0.02). Comparison of the morphology of kisspeptin-induced LH pulses in healthy men with that of GnRH-induced LH pulses in men with isolated GnRH deficiency suggests that a single iv bolus of kisspeptin triggered sustained GnRH release lasting approximately 17 min. Furthermore, kisspeptin reset the GnRH pulse generator, as it not only induced an immediate LH pulse but also delayed the next endogenous pulse by an interval approximating the normal interpulse interval. Conclusions: As the first known agent capable of resetting the hypothalamic GnRH pulse generator, kisspeptin can be used as a physiological tool for studying GnRH pulse generation and opens a door to understanding the mechanisms of biological clocks in general.
- 1 June 2011
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 96 (6) , E908-E915
Open AccessKisspeptin Resets the Hypothalamic GnRH Clock in Men
Context: Reproduction in all mammals is controlled by a hypothalamic clock that produces periodic secretory pulses of GnRH, but how the timing of these pulses is determined is poorly understood. The neuropeptide kisspeptin potently and selectively stimulates the secretion of GnRH. Although this property of kisspeptin is well described, the effects of kisspeptin on endogenous GnRH pulse generation remain largely unexplored. Objective: The objective of the study was to detail the effects of kisspeptin on GnRH secretion, as reflected by LH secretion, in men. Participants: Thirteen healthy adult men participated in the study. Intervention: The intervention was the administration of a single iv bolus of the C-terminal decapeptide of kisspeptin (amino acids 112–121 of the parent protein). Results: Kisspeptin induced an immediate LH pulse, regardless of the timing of the previous endogenous pulse. The kisspeptin-induced pulses were on average larger than endogenous pulses (amplitude 5.0 ± 1.0 vs. 2.1 ± 0.3 mIU/ml, P = 0.02). Comparison of the morphology of kisspeptin-induced LH pulses in healthy men with that of GnRH-induced LH pulses in men with isolated GnRH deficiency suggests that a single iv bolus of kisspeptin triggered sustained GnRH release lasting approximately 17 min. Furthermore, kisspeptin reset the GnRH pulse generator, as it not only induced an immediate LH pulse but also delayed the next endogenous pulse by an interval approximating the normal interpulse interval. Conclusions: As the first known agent capable of resetting the hypothalamic GnRH pulse generator, kisspeptin can be used as a physiological tool for studying GnRH pulse generation and opens a door to understanding the mechanisms of biological clocks in general.
- 1 April 2010
- Published by S. Karger AG in Hormone Research in Paediatrics
- Vol. 73 (5) , 312-319
Central Precocious Puberty due to Hypothalamic Hamartomas Correlates with Anatomic Features but Not with Expression of GnRH, TGFα, or KISS1
Background/Aims: Hypothalamic hamartomas are the most common identifiable cause of central precocious puberty (CPP). Hamartoma characteristics proposed to be associated with CPP include specific anatomic features and expression of molecules such as gonadotropin-releasing hormone (GnRH), transforming growth factor α (TGFα), and GRM1A, which encodes the type 1 metabotropic glutamate receptor α isoform. We sought to determine whether hamartomas that cause CPP could be distinguished by anatomic features, expression of these molecules, or expression of KISS1, whose products signal through the receptor GPR54 to stimulate GnRH release. Methods: Clinical records and radiologic images were reviewed for 18 patients who underwent hamartoma resection for intractable seizures; 7 had precocious puberty. Resected tissue was examined for expression of GnRH, GnRH receptor (GnRHR), TGFα, KISS1, GPR54, and GRM1A. Results: Hypothalamic hamartomas associated with CPP were more likely to contact the infundibulum or tuber cinereum and were larger than hamartomas not associated with CPP. GnRH, TGFα, and GnRHR were expressed by all hamartomas studied. Expression of KISS1, GPR54, and GRM1A did not differ significantly between hamartomas associated and not associated with CPP. Conclusion: Anatomic features rather than expression patterns of candidate molecules distinguish hypothalamic hamartomas that are associated with CPP from those that are not.
- 1 April 2010
- Published by S. Karger AG in Hormone Research in Paediatrics
- Vol. 73 (5) , 312-319
Central Precocious Puberty due to Hypothalamic Hamartomas Correlates with Anatomic Features but Not with Expression of GnRH, TGFα, or KISS1
Background/Aims: Hypothalamic hamartomas are the most common identifiable cause of central precocious puberty (CPP). Hamartoma characteristics proposed to be associated with CPP include specific anatomic features and expression of molecules such as gonadotropin-releasing hormone (GnRH), transforming growth factor α (TGFα), and GRM1A, which encodes the type 1 metabotropic glutamate receptor α isoform. We sought to determine whether hamartomas that cause CPP could be distinguished by anatomic features, expression of these molecules, or expression of KISS1, whose products signal through the receptor GPR54 to stimulate GnRH release. Methods: Clinical records and radiologic images were reviewed for 18 patients who underwent hamartoma resection for intractable seizures; 7 had precocious puberty. Resected tissue was examined for expression of GnRH, GnRH receptor (GnRHR), TGFα, KISS1, GPR54, and GRM1A. Results: Hypothalamic hamartomas associated with CPP were more likely to contact the infundibulum or tuber cinereum and were larger than hamartomas not associated with CPP. GnRH, TGFα, and GnRHR were expressed by all hamartomas studied. Expression of KISS1, GPR54, and GRM1A did not differ significantly between hamartomas associated and not associated with CPP. Conclusion: Anatomic features rather than expression patterns of candidate molecules distinguish hypothalamic hamartomas that are associated with CPP from those that are not.
- 18 November 2009
- Published by Wiley in Journal of Neuroendocrinology
- Vol. 21 (12) , 1015-1023
Kisspeptin/Gpr54‐Independent Gonadotrophin‐Releasing Hormone Activity in Kiss1 and Gpr54 Mutant Mice
The kisspeptin/Gpr54 signalling pathway plays a critical role in reproduction by stimulating the secretion of gonadotrophin‐releasing hormone (GnRH), yet mice carrying mutations in Kiss1 (which encodes kisspeptin) or Gpr54 exhibit partial sexual maturation. For example, a proportion of female Kiss1−/− and Gpr54−/− mice exhibit vaginal oestrus, and some male Kiss1−/− and Gpr54−/− mice exhibit spermatogenesis. To characterise this partial sexual maturation, we examined the vaginal cytology of female Kiss1−/− and Gpr54−/− mice over time. Almost all mutant mice eventually enter oestrus, and then spontaneously transition from oestrus to dioestrus and back to oestrus again. These transitions are not associated with ovulation, and the frequency of these transitions increases with age. The oestrus exhibited by female Kiss1−/− and Gpr54−/− mice was disrupted by the administration of the competitive GnRH antagonist acyline, which also resulted in lower uterine weights and, in Kiss1−/− mice, lower serum follicle‐stimulating hormone (FSH) and luteinising hormone (LH) concentrations. Similarly, male Kiss1−/− and Gpr54−/− mice treated with acyline had smaller testicular sizes and an absence of mature sperm. In addition to examining intact Kiss1−/− and Gpr54−/− mice, we also assessed the effects of acyline on gonadotrophin concentrations in gonadectomised mice. Gonadectomy resulted in a significant increase in serum FSH concentrations in male Gpr54−/− and Kiss1−/− mice. Acyline administration to gonadectomised Kiss1−/− and Gpr54−/− male mice lowered serum FSH and LH concentrations significantly. By contrast to males, gonadectomy did not result in significant gonadotrophin changes in female Kiss1−/− and Gpr54−/− mice, but acyline administration was followed by a decrease in LH concentrations. These results demonstrate that, although kisspeptin signalling is critical for the high levels of GnRH activity required for normal sexual maturation and for ovulation, Kiss1−/− and Gpr54−/− mice retain some degree of GnRH activity. This GnRH activity is sufficient to produce significant effects on vaginal cytology and uterine weights in female mice and on spermatogenesis and testicular weights in male mice.
- 18 November 2009
- Published by Wiley in Journal of Neuroendocrinology
- Vol. 21 (12) , 1015-1023
Kisspeptin/Gpr54‐Independent Gonadotrophin‐Releasing Hormone Activity in Kiss1 and Gpr54 Mutant Mice
The kisspeptin/Gpr54 signalling pathway plays a critical role in reproduction by stimulating the secretion of gonadotrophin‐releasing hormone (GnRH), yet mice carrying mutations in Kiss1 (which encodes kisspeptin) or Gpr54 exhibit partial sexual maturation. For example, a proportion of female Kiss1−/− and Gpr54−/− mice exhibit vaginal oestrus, and some male Kiss1−/− and Gpr54−/− mice exhibit spermatogenesis. To characterise this partial sexual maturation, we examined the vaginal cytology of female Kiss1−/− and Gpr54−/− mice over time. Almost all mutant mice eventually enter oestrus, and then spontaneously transition from oestrus to dioestrus and back to oestrus again. These transitions are not associated with ovulation, and the frequency of these transitions increases with age. The oestrus exhibited by female Kiss1−/− and Gpr54−/− mice was disrupted by the administration of the competitive GnRH antagonist acyline, which also resulted in lower uterine weights and, in Kiss1−/− mice, lower serum follicle‐stimulating hormone (FSH) and luteinising hormone (LH) concentrations. Similarly, male Kiss1−/− and Gpr54−/− mice treated with acyline had smaller testicular sizes and an absence of mature sperm. In addition to examining intact Kiss1−/− and Gpr54−/− mice, we also assessed the effects of acyline on gonadotrophin concentrations in gonadectomised mice. Gonadectomy resulted in a significant increase in serum FSH concentrations in male Gpr54−/− and Kiss1−/− mice. Acyline administration to gonadectomised Kiss1−/− and Gpr54−/− male mice lowered serum FSH and LH concentrations significantly. By contrast to males, gonadectomy did not result in significant gonadotrophin changes in female Kiss1−/− and Gpr54−/− mice, but acyline administration was followed by a decrease in LH concentrations. These results demonstrate that, although kisspeptin signalling is critical for the high levels of GnRH activity required for normal sexual maturation and for ovulation, Kiss1−/− and Gpr54−/− mice retain some degree of GnRH activity. This GnRH activity is sufficient to produce significant effects on vaginal cytology and uterine weights in female mice and on spermatogenesis and testicular weights in male mice.